# Vivendy Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vivendy-therapeutics

- Industry: Biotechnology
- Headquarters: Basel, Switzerland
- Website: www.vivendy.ch
- Total disclosed funding: $30M
- Latest round: Series A (Jun 18, 2008)
- Investors on record: 4

## About

Vivendy Therapeutics is a Switzerland-based company that operates as a developer of an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease based on a gene deficiency.

## Funding rounds

- Series A, Jun 18, 2008, $15M — TVM Capital Life Science, EQT Life Sciences, BioMed Partners, Aescap Venture
- Series A, Jan 14, 2008, $15M — TVM Capital Life Science, EQT Life Sciences, BioMed Partners

## Investors

- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A
- BioMed Partners (https://capitalatlas.ai/funds/biomed-partners) — Series A
- Aescap Venture (https://capitalatlas.ai/funds/aescap-venture) — Series A